| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Senior Vice President, Finance
1 company
Catinazzo Thomas is a Chief Financial Officer at Relay Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $2.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 27, 2023 | RLAY Relay Therapeutics, Inc. | Chief Financial Officer | Sell | 294 | $12.12 | $3,563.28 | -0.2% | -33.1% | -50.2% | |
| Apr 28, 2023 | RLAY Relay Therapeutics, Inc. | Chief Financial Officer | Sell | 863 | $11.16 | $9,631.08 | -0.6% | +2.9% | -44.0% | |
| Mar 27, 2023 | RLAY Relay Therapeutics, Inc. | Chief Financial Officer | Sell | 347 | $15.36 | $5,329.92 | -0.2% | -21.8% | -51.1% | |
| Jan 30, 2023 | RLAY Relay Therapeutics, Inc. | Chief Financial Officer | Sell | 864 | $21.56 | $18,627.84 | -0.6% | -45.4% | -54.5% | |
| Dec 27, 2022 | RLAY Relay Therapeutics, Inc. | Chief Financial Officer | Sell | 445 | $14.49 | $6,448.05 | -0.9% | +7.4% | -20.9% | |
| Oct 28, 2022 | RLAY Relay Therapeutics, Inc. | Chief Financial Officer | Sell | 1,099 | $21.54 | $23,672.46 | -2.1% | -10.3% | -73.1% | |
| Sep 27, 2022 | RLAY Relay Therapeutics, Inc. | Chief Financial Officer | Sell | 443 | $22.73 | $10,069.39 | -0.8% | -38.1% | -64.5% | |
| Sep 8, 2022 | RLAY Relay Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 26,257 | $30.00 | $787,710.00 | -33.5% | -44.4% | -69.0% | |
| Jul 28, 2022 | RLAY Relay Therapeutics, Inc. | Chief Financial Officer | Sell | 734 | $21.26 | $15,604.84 | -1.4% | +7.8% | -40.1% | |
| Jun 27, 2022 | RLAY Relay Therapeutics, Inc. | Chief Financial Officer | Sell | 300 | $20.31 | $6,093.00 | -0.6% | +17.9% | -32.7% |